Cargando…
Association of HbA(1C) Variability and Renal Progression in Patients with Type 2 Diabetes with Chronic Kidney Disease Stages 3–4
Little is known about the predictive value of glycosylated hemoglobin (HbA(1C)) variability in patients with advanced chronic kidney disease (CKD). The aim of this study was to investigate whether HbA(1C) variability is associated with progression to end-stage renal disease in diabetic patients with...
Autores principales: | Lee, Mei-Yueh, Huang, Jiun-Chi, Chen, Szu-Chia, Chiou, Hsin-Ying Clair, Wu, Pei-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321040/ https://www.ncbi.nlm.nih.gov/pubmed/30567403 http://dx.doi.org/10.3390/ijms19124116 |
Ejemplares similares
-
Greater HbA(1c) variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease
por: Lee, Mei-Yueh, et al.
Publicado: (2017) -
HbA1C Variability and the Risk of Renal Status Progression in Diabetes Mellitus: A Meta-Analysis
por: Cheng, Dongsheng, et al.
Publicado: (2014) -
Association of poorly controlled HbA(1c) with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease
por: Chen, Sheng-Jen, et al.
Publicado: (2022) -
The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009) -
Greater low-density lipoprotein cholesterol variability is associated with increased progression to dialysis in patients with chronic kidney disease stage 3
por: Lin, Yu-Hsuan, et al.
Publicado: (2017)